Innovita Biological Technology Co., Ltd. (SHA:688253)
China · Delayed Price · Currency is CNY 34.80
+1.16 (3.45%)
At close: Mar 6, 2026
SHA:688253 Revenue
In the year 2025, Innovita Biological Technology had annual revenue of 422.03M CNY, down -32.08%. Innovita Biological Technology had revenue of 91.63M in the quarter ending December 31, 2025, a decrease of -8.88%.
Revenue
422.03M
Revenue Growth
-32.08%
P/S Ratio
11.12
Revenue / Employee
771.54K
Employees
558
Market Cap
4.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 422.03M | -199.36M | -32.08% |
| Dec 31, 2024 | 621.39M | 143.37M | 29.99% |
| Dec 31, 2023 | 478.02M | 31.40M | 7.03% |
| Dec 31, 2022 | 446.62M | 119.71M | 36.62% |
| Dec 31, 2021 | 326.91M | -710.19M | -68.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hefei Lifeon Pharmaceutical | 1.47B |
| Pulike Biological Engineering | 1.10B |
| ChemPartner PharmaTech | 1.07B |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Assure Tech (Hangzhou) | 453.58M |
| Hangzhou Biotest Biotech | 448.37M |
| Beijing Scitop Bio-tech | 351.47M |